48,835
edits
Difference between revisions of "Malignant melanoma"
Jump to navigation
Jump to search
m
→Regression of melanoma
(nl update 24) |
|||
| Line 111: | Line 111: | ||
*Complete regression and partial regression >75% of the lesion are a poor prognostic feature.<ref name=pmid16446717>{{Cite journal | last1 = Crowson | first1 = AN. | last2 = Magro | first2 = CM. | last3 = Mihm | first3 = MC. | title = Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. | journal = Mod Pathol | volume = 19 Suppl 2 | issue = | pages = S71-87 | month = Feb | year = 2006 | doi = 10.1038/modpathol.3800517 | PMID = 16446717 }}</ref> | *Complete regression and partial regression >75% of the lesion are a poor prognostic feature.<ref name=pmid16446717>{{Cite journal | last1 = Crowson | first1 = AN. | last2 = Magro | first2 = CM. | last3 = Mihm | first3 = MC. | title = Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. | journal = Mod Pathol | volume = 19 Suppl 2 | issue = | pages = S71-87 | month = Feb | year = 2006 | doi = 10.1038/modpathol.3800517 | PMID = 16446717 }}</ref> | ||
Note: | |||
*[[Melanocytic lesions]] in general, ''not'' only melanoma, may regress.<ref name=Ref_Derm476>{{Ref Derm|476}}</ref><ref name=pmid21029398>{{Cite journal | last1 = Speeckaert | first1 = R. | last2 = van Geel | first2 = N. | last3 = Vermaelen | first3 = KV. | last4 = Lambert | first4 = J. | last5 = Van Gele | first5 = M. | last6 = Speeckaert | first6 = MM. | last7 = Brochez | first7 = L. | title = Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy. | journal = Pigment Cell Melanoma Res | volume = 24 | issue = 2 | pages = 334-44 | month = Apr | year = 2011 | doi = 10.1111/j.1755-148X.2010.00799.x | PMID = 21029398 }}</ref> | |||
=====Microscopic===== | =====Microscopic===== | ||
Features - all required: | Features - all required: | ||